COVID-19 / Coronavirus

Harbour BioMed Announces Dosing of First Patients in Two Phase II Clinical Studies of Batoclimab (HBM9161) for the Treatment of Myasthenia Gravis and Immune Thrombocytopenia

2020-09-30 21:50 5137

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Sept. 30, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global, clinical-stage, bio-pharmaceutical company announced today the dosing of the first patient in two separate Phase II clinical trials of Batoclimab (HBM 9161), a fully human...

MARii and Sengenics Launch ImmuSAFE® - World's First Multi-Antigen, Epitope Specific, Fully Quantitative COVID-19 Test

2020-09-30 20:21 5704

CYBERJAYA, Malaysia, Sept. 30, 2020 /PRNewswire/ -- The Malaysia Automotive, Robotics and IoT Institute (MARii) and Sengenics Sdn. Bhd. launched the ImmuSAFE COVID+ biochip, at MARii's headquarters, Cyberjaya. From left: Dr. Faizal Anwar, MAR...

I-Mab Receives China CDE Approval to Initiate Phase 3 Clinical Trial of Eftansomatropin in Pediatric Patients with Growth Hormone Deficiency

2020-09-30 20:00 11604

SHANGHAI and GAITHERSBURG, Md., Sept. 30, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the China Center for Drug Evaluation (CDE) has app...

TaiGen Biotechnology Out-Licensed Taigexyn (Nemonoxacin) to Luminarie Canada for Canada, Australia and New Zealand

2020-09-30 15:51 1628

TAIPEI, Sept. 30, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen")(Taiwan: 4157) today announced that they have signed an exclusive licensing agreement with Luminarie Canada Inc. ("Luminarie"), a leading Canadian pharmaceutical company, to develop and commercialize Taigexyn® ...

HeyGears Announces its Latest Innovations in Digital Manufacturing Solutions: A Clear Aligner Production Solution and UltraCraft A2D 4K

2020-09-30 13:17 2777

GUANGZHOU, China, Sept. 30, 2020 /PRNewswire/ -- At Dental South China International Expo, HeyGears announces two of its latest innovations in digital manufacturing solutions. First, HeyGears' clear aligner production solution that allows 24/7 mass production of clear aligner models and digitally...

Statement from Bill & Melinda Gates Foundation CEO Mark Suzman on Momentum in Global COVID-19 Response

2020-09-30 12:01 2241

SEATTLE, Sept. 30, 2020 /PRNewswire/ -- The death toll from COVID-19 passed one million this week. It is a sobering moment. But there is cause for optimism as recent days have seen a significant surge in momentum around global cooperation, which is our greatest strength when it comes to consignin...

BioGX launches CE-IVD Marked COVID-19, Influenza A/B, RSV Combo RT-PCR Test for the BD MAX™ System

2020-09-30 06:06 2606

AMSTERDAM, Sept. 30, 2020 /PRNewswire/ -- BioGX BV, the European subsidiary of Birmingham, Alabama based BioGX, announced availability of a CE-IVD marked test for simultaneous detection of SARS-CoV-2, Influenza A, Influenza B and Respiratory Syncytial Virus RNA in a patient sample using the BD MA...

Data Science to Accelerate Drug Discovery with Artificial Intelligence and Machine Learning, Says Frost & Sullivan

2020-09-29 22:10 2922

Pharmaceutical companies and hospitals are adopting data science rapidly, and its application is going to be established in all branches of healthcare SANTA CLARA, Calif., Sept. 29, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Data Science Impacting the Pharmaceutical Industry, finds t...

Guide IR Fever Warning Systems Authorized by Health Canada as Medical Device for Uses Related to COVID-19

2020-09-29 19:02 1571

CALGARY, AB, Sept. 29, 2020 /PRNewswire/ -- Guide Sensmart ("the Company"), a world leading manufacturer of infrared thermal imaging systems, has had its IR236 IR Fever Warning System added to the list of authorized medical devices for uses related to COVID-19 by Health Canada. The authorized dev...

Daewoong Pharmaceutical announces Korea's first-ever SGLT2 inhibitor for diabetes treatment

2020-09-28 20:00 1789

* Daewoong Pharmaceutical's enavogliflozin to demonstrate remarkable blood glucose lowering effect and favorable safety in type 2 diabetic patients through phase 2 clinical trial * Presented and demonstrated the result of phase 2 clinical trial in Korean patients with type 2 diabetes at the i...

World Heart Federation says perfect storm for heart disease created by COVID-19

2020-09-28 19:05 2985

GENEVA, Sept. 28, 2020 /PRNewswire/ -- COVID-19 is creating a perfect storm for heart health, the World Heart Federation (WHF) warns on World Heart Day. Three main factors are contributing to this. First, people with COVID-19 and heart disease are among those with the highest risk of death and se...

Mumbai Municipal Commissioner I.S. Chahal Honoured With Global 'Covid Crusader Award-2020'

2020-09-28 18:08 2954

PUNE, India, Sept. 28, 2020 /PRNewswire/ -- Iqbal Singh Chahal, I.A.S., Municipal Commissioner of the Municipal Corporation ofGreater Mumbai, has become the first Indian bureaucrat to be recognised and receive global acknowledgment for his contribution in controlling the novel coronavirus infect...

Carmine Therapeutics named as one of FierceBiotech's "Fierce 15" Biotech Companies of 2020

2020-09-28 18:00 1299

CAMBRIDGE, Mass., Sept. 28, 2020 /PRNewswire/ -- Carmine Therapeutics announced today that it has been named by FierceBiotech as one of 2020's Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry.  The 2020 Fierce 15 com...

TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Injection) ORIENT-32 Study Met Its Primary Endpoints of Progression-Free Survival and Overall Survival in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma (HCC)

2020-09-28 10:15 5837

SAN FRANCISCO and SUZHOU, China, Sept. 28, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major d...

Zymo Research Granted CE IVD Mark for Sample Collection Devices

2020-09-28 07:00 3548

IRVINE, California, Sept. 28, 2020 /PRNewswire/ -- Zymo Research announced that three of itsDNA/RNA Shield™ collection devices: 1) DNA/RNA Shield™ collection tube w/ swab, 2) DNA/RNA Shield™ Saliva/Sputum Collection Kit, and 3) DNA/RNA Shield™ Fecal Collection Tube are now CE IVD marked for in vi...

Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study

2020-09-28 06:00 2430

* New preventative nasal spray treatment that could protect people from COVID-19 infection and prevent transmission announced * Novel therapy developed by Australian biotech company, Ena Respiratory, shown to significantly reduce COVID-19 virus levels in the nose and throat, in a gold-standar...

Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study

2020-09-28 04:00 5390

* New preventative nasal spray treatment that could protect people from COVID-19 infection and prevent transmission announced * Novel therapy developed by Australian biotech company, Ena Respiratory, shown to significantly reduce COVID-19 virus levels in the nose and throat, in a gold-standar...

Happiness Biotech Announces $2.25 Million Private Placement In Support of Happy Buy

2020-09-25 22:30 26255

NANPING, China, Sept. 25, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company has entered into certain securities purchase agreement with three non-U.S. inve...

Solvay introduces Actizone™, a long-lasting antimicrobial cleaning technology

2020-09-24 21:46 3856

Durable surface protection is now within easy reach with Actizone™, a patented technology that delivers 24-hour antimicrobial performance. BRUSSELS, Sept. 24, 2020 /PRNewswire/ -- Solvay is proud to introduce Actizone™

New Centre for Medicines Research Report from Clarivate Indicates Drug Development Timelines are Shortest Since 2013

2020-09-24 16:15 8724

Pharmaceutical R&D industry report provides insights into what's behind decline in global NME outputs and reveals implications of decreased projected expenditures LONDON, Sept. 24, 2020 /PRNewswire/ -- Clarivate Plc (NYSE:CCC), a global leader in providing trusted information and insights to acc...

1 ... 131132133134135136137 ... 226